CRSBP-1/LYVE-1 ligands disrupt lymphatic intercellular adhesion by inducing tyrosine phosphorylation and internalization of VE-cadherin

Journal of Cell Science

Volumn 124, Issue 8, 2011, Pages 1231-1244

  Hou, Wei Hsien ^a   Liu, I Hua ^a   Tsai, Cheng C ^b   Johnson, Frank E ^a   Huang, Shuan Shian ^c   Huang, Jung San ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WCP Laboratories Inc   (United States)

^c Auxagen Inc   (United States)

Author keywords

Endothelial cell permeability; Interstitial lymphatic transit; PDGF type receptor; Tyrosine phosphorylation; VE cadherin intercellular junctions

Indexed keywords

BETA CATENIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN; PROTEIN CRSBP 1; PROTEIN LYVE 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ADHESION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; INTERNALIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION;

ANIMALS; ANTIGENS, CD; BETA CATENIN; CADHERINS; CELL ADHESION; CELL LINE; ENDOTHELIAL CELLS; HYALURONIC ACID; LIGANDS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHORYLATION; PROTEIN BINDING; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; TYROSINE;

MUS;

EID: 79953158398     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.078154     Document Type: Article

References (43)

1. Adam, A. P., Sharenko, A. L., Pumiglia, K. and Vincent, P. A. (2010). Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers. J. Biol. Chem. 285, 7045-7055.
2. Alitalo, K. and Carmeliet, P. (2002). Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 1, 219-227.
3. Aukland, K. and Reed, R. K. (1993). Interstitil-lymphatic mechanisms in the control of extracellular fluid volume. Am. J. Physiol. 73, 1-75.
4. Baluk, P., Fuxe, J., Hashizume, H., Romano, T., Lashnits, E., Butz, S., Vestweber, D., Corada, M., Molendini, C., Dejana, E. et al. (2007). Functionally specialized junctions between endothelial cells of lymphatic vessels. J. Exp. Med. 204, 2349-2362.
5. Banerji, S., Ni, J., Wang, S. X., Clasper, S., Su, J., Tammi, R., Jones, M. and Jackson, D. G. (1999). LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 144, 789-801.
6. Boccellino, M., Camussi, G., Giovane, A., Ferro, L., Calderaro, V., Balestrieri, C. and Quagliuolo, L. (2005). Platelet-activating factor regulates cadherin-catenin adhesion system expression and beta-catenin phosphorylation during Kaposi's sarcoma cell motility. Am. J. Pathol. 166, 1515-1522.
7. Boensch, C., Kuo, M. D., Connolly, D. T., Huang, S. S. and Huang, J. S. (1995). Identification, purification, and characterization of cell-surface retention sequencebinding proteins from human SK-Hep cells and bovine liver plasma membranes. J. Biol. Chem. 270, 1807-1816.
8. Boensch, C., Huang, S. S., Connolly, D. T. and Huang, J. S. (1999). Cell surface retention sequence binding protein-1 interacts with the v-sis gene product and plateletderived growth factor beta-type receptor in simian sarcoma virus-transformed cells. J. Biol. Chem. 274, 10582-10589.
9. Cao, R., Bjorndahl, M. A., Religa, P., Clasper, S., Garvin, S., Galter, D., Meister, B., Ikomi, F., Tritsaris, K., Dissing, S. et al. (2006). PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 6, 333-345.
10. Cao, Y. (2005). Direct role of PDGF-BB in lymphangiogenesis and lymphatic metastasis. Cell Cycle 4, 228-230.
11. Carmeliet, P., Ng, Y. S., Nuyens, D., Theilmeier, G., Brusselmans, K., Cornelissen, I., Ehler, E., Kakkar, V. V., Stalmans, I., Mattot, V. et al. (1999). Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat. Med. 5, 495-502.
12. Dejana, E., Orsenigo, F. and Lampugnani, M. G. (2008). The role of adherens junctions and VE-cadherin in the control of vascular permeability. J. Cell Sci. 121, 2115-2122.
13. Eccles, S., Paon, L. and Sleeman, J. (2007). Lymphatic metastasis in breast cancer: importance and new insights into cellular and molecular mechanisms. Clin. Exp. Metastasis 24, 619-636.
14. Esser, S., Lampugnani, M. G., Corada, M., Dejana, E. and Risau, W. (1998). Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J. Cell Sci. 111, 1853-1865.
15. Ferrara, N. (2004). Vascular endothelial growth factor: basic science and clinical progress. Endocr. Rev. 25, 581-611.
16. Gavard, J. and Gutkind, J. S. (2006). VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat. Cell Biol. 8, 1223-1234.
17. Hartsock, A. and Nelson, W. J. (2008). Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim. Biophys. Acta 1778, 660-669.
18. He, Y., Rajantie, I., Pajusola, K., Jeltsch, M., Holopainen, T., Yla-Herttuala, S., Harding, T., Jooss, K., Takahashi, T. and Alitalo, K. (2005). Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res. 65, 4739-4746.
19. Hellberg, C., Ostman, A. and Heldin, C.-H. (2010). PDGF and vessel maturation. Recent Results Cancer Res. 180, 103-114.
20. Houck, K. A., Ferrara, N., Winer, J., Cachianes, G., Li, B. and Leung, D. W. (1991). The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol. 5, 1806-1814.
21. Huang, S. S., Tang, F. M., Huang, Y. H., Liu, I.-H., Hsu, S. C., Chen, S. T. and Huang, J. S. (2003). Cloning, expression, characterization, and role in autocrine cell growth of cell surface retention sequence binding protein-1. J. Biol. Chem. 278, 43855-43869.
22. Huang, S. S., Liu, I.-H., Smith, T., Shah, M. R., Johnson, F. E. and Huang, J. S. (2006). CRSBP-1/LYVE-1-null mice exhibited identifiable morphological and functional alterations of lymphatic capillary vessels. FEBS Lett. 580, 6259-6268.
23. Jackson, D. G. (2003). The lymphatics revisited: new perspectives from the hyaluronan receptor LYVE-1. Trends Cardiovasc. Med. 13, 1-7.
24. Ji, R. C. (2009). Lymph node lymphangiogenesis: a new concept for modulating tumor metastasis and inflammatory process. Histol. Histopathol. 24, 377-384.
25. Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N. and Alitalo, K. (1996). A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15, 290-298.
26. Joukov, V., Sorsa, T., Kumar, V., Jeltsch, M., Claesson-Welsh, L., Cao, Y., Saksel, O., Kalkkinen, N. and Alitalo, K. (1997). Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J. 16, 3898-3911.
27. Jussila, L. and Alitalo, K. (2002). Vascular growth factors and lymphangiogenesis. Physiol. Rev. 82, 673-700.
28. Knudsen, K. A., Soler, A. P., Johnson, K. R. and Wheelock, M. J. (1995). Interaction of alpha-actinin with the cadherin/catenin cell-cell adhesion complex via alpha-catenin. J. Cell Biol. 130, 67-77.
29. Kovalenko, M., Rönnstrand, L., Heldin, C.-H., Loubtchenkov, M., Gazit, A., Levitzki, A. and Böhmer, F. D. (1997). Phosphorylation site-specific inhibition of plateletderived growth factor beta-receptor autophosphorylation by the receptor blocking tyrphostin AG1296. Biochemistry 36, 6260-6269.
30. LaRochelle, W. J., May-Siroff, M., Robbins, K. C. and Aaronson, S. A. (1991). A novel mechanism regulating growth factor association with the cell surface: identification of a PDGF retention domain. Genes Dev. 5, 1191-1199.
31. Leak, L. V. (1976). The structure of lymphatic capillaries in lymph formation. Fed. Proc. 35, 1863-1871.
32. Lokeshwar, V. B., Huang, S. S. and Huang, J. S. (1990). Intracellular turnover, novel secretion, and mitogenically active intracellular forms of v-sis gene product in simian sarcoma virus-transformed cells. Implications for intracellular loop autocrine transformation. J. Biol. Chem. 265, 1665-1675.
33. Ostman, A., Andersson, M., Betsholtz, C., Westermark, B. and Heldin, C.-H. (1991). Identification of a cell retention signal in the B-chain of platelet-derived growth factor and in the long splice version of the A-chain. Cell Regul. 2, 503-512.
34. Otterness, I. G. and Moore, P. F. (1988). Carregeenan foot edema test. Methods Enzymol. 162, 320-327.
35. Piedra, J., Miravet, S., Castaño, J., Pálmer, H. G., Heisterkamp, N., García de Herreros, A. and Duñach, M. (2003). p120 Catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha-catenin interaction. Mol. Cell. Biol. 23, 2287-2297.
36. Potter, M. D., Barbero, S. and Cheresh, D. A. (2005). Tyrosine phosphorylation of VEcadherin prevents binding of p120- and beta-catenin and maintains the cellular mesenchymal state. J. Biol. Chem. 280, 31906-31912.
37. Prevo, R., Banerji, S., Ferguson, D. J., Clasper, S. and Jackson, D. G. (2001). Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J. Biol. Chem. 276, 19420-19430.
38. Robbiani, D. F., Finch, R. A., Jager, D., Muller, W. A., Sartorelli, A. C. and Randolph, G. J. (2000). The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 103, 757-768.
39. Skobe, M. and Detmar, M. (2000). Structure, function, and molecular control of the skin lymphatic system Expression of vascular endothelial growth factor induces an invasive phenotype in human squamous cell carcinomas. J. Investig. Dermatol. Symp. Proc. 5, 14-19.
40. Teriete, P., Banerji, S., Noble, M., Blundell, C. D., Wright, A. J., Pickford Lowe, E., Mahoney, D. J., Tammi, M. I., Kahmann, J. D., Campbell, I. D. et al. (2004). Structure of the regulatory hyaluronan binding domain in the inflammatory leukocyte homing receptor CD44. Mol. Cell 13, 483-496.
41. Vincent, L., Kermani, P., Young, L. M., Cheng, J., Zhang, F., Shido, K., Lam, G., Bompais-Vincent, H., Zhu, Z., Hicklin, D. J. et al. (2005). Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling. J. Clin. Invest. 115, 2992-3006.
42. Vincent, P. A., Xiao, K., Buckley, K. M. and Kowalczyk, A. P. (2004). VE-cadherin: adhesion at arm's length. Am. J. Physiol. Cell Physiol. 286, C987-C997.
43. Wise, L. E., Cannavacciulo, R., Cravatt, B. F., Martin, B. F. and Lichtman, A. H. (2007). Evaluation of fatty acid amides in the carrageenan-induced paw edema model. Neuropharmacology 54, 181-188.